Management of Diabetic Dyslipidemia with Adjunctive Classical Ayurvedic Therapy in Type 2 Diabetes Mellitus

Abstract

Diabetic dyslipidemia is a common metabolic complication of type 2 diabetes mellitus (T2DM), characterized by abnormal lipid metabolism that significantly elevates cardiovascular risk. In Ayurveda, this condition correlates with Medoroga occurring as a sequela of Prameha, where Agnimandya (impaired metabolic fire), Ama (toxic metabolic bioproducts), and Kapha‑Meda Dushti drive pathogenesis. Ayurvedic interventions aim to correct these root metabolic disturbances. Case Presentation: A 63‑year‑old male with a 10‑year history of T2DM presented with unexplained weight gain and impaired digestion. Despite ongoing oral hypoglycemic medication, his glycemic control remained suboptimal (HbA1c: 8.2%, FBS: 144mg/dL, PPBS: 230mg/dL). He was concurrently diagnosed with diabetic dyslipidemia, showing an elevated serum LDL cholesterol level of 171.3mg/dL. The patient was treated with Phalatrikadi Kwatha, Navaka Guggulu, and Triphala Churna as an adjunct to his ongoing oral hypoglycemic therapy, alongside customized Ayurvedic dietary and lifestyle modifications (Pathya Ahara‑Vihara). Results: Following 3 months of conservative management, the patient demonstrated significant improvement in clinical symptoms, glycemic indices (HbA1c decreased to 6.8%), and lipid profile metrics (serum LDL reduced to 152.6mg/dL), with zero adverse drug reactions. Conclusion: This case suggests that classical Ayurvedic formulations, when safely integrated as an adjunct to conventional oral hypoglycemic therapy, can significantly improve lipid pathways and metabolic homeostasis in diabetic dyslipidemia.